🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare two treatment regimes, namely...
Status
Recruiting
Location
Tata Memorial Centre
Start Date
2024-03-07
Trial ID
NCT06214572
The standard of care for muscle-invasive bladder cancer (MIBC) is radical c...
Status
Completed
Location
ICO Badalona
Start Date
2018-11-16
Trial ID
NCT03534492
Treatments Being Tested
This is a two-part Phase 1/2 dose escalation and dose expansion study of an...
Status
Completed
Location
Research Facility
Start Date
2017-09-07
Trial ID
NCT02963831
Treatments Being Tested
This is a phase II, single-arm, multicenter study to evaluate the activity ...
Status
Recruiting
Location
AUSL-IRCCS of Reggio Emilia
Start Date
2024-01-16
Trial ID
NCT06464068
Treatments Being Tested
This is an open-label, multicenter, 2-arm study to evaluate the safety and ...
Status
Completed
Location
Research Facility
Start Date
2017-12-20
Trial ID
NCT03164772
Treatments Being Tested
Combined-modality treatment of localized muscle invasive bladder cancer inc...
Status
Completed
Location
Instituto Catalán de Oncología Badalona
Start Date
2018-11-19
Trial ID
NCT03702179
Treatments Being Tested
This is a single arm phase II study of pemigatinib and durvalumab combinati...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2026-01-27
Trial ID
NCT06728410
Treatments Being Tested
This is a two arm, randomized, phase II study of patients with advanced KRA...
Status
Withdrawn
Location
Henry Ford Health System
Start Date
2021-04-06
Trial ID
NCT04470674
Treatments Being Tested
The purpose of this study is to find out what effects durvalumab has on bla...
Status
Active Not Recruiting
Location
Tom Baker Cancer Centre
Start Date
2019-10-25
Trial ID
NCT03768570
Treatments Being Tested
This study aims to assess the efficacy of durvalumab in combination with ra...
Status
Completed
Location
Centre Oscar Lambret, CLCC UNICANCER
Start Date
2018-12-05
Trial ID
NCT03777813
Treatments Being Tested